A significant portion of the introductory section of this article was taken from a paper by Vessecchi et al. previously published in the Journal of Mass Spectrometry. Unfortunately, the authors omitted to acknowledge a proper citation of the original paper.
The last sentence of the first paragraph on page 370 should read: Techniques for the characterization and structural elucidation of this type of compounds have become mandatory from the perspective of clinical and preclinical trials. [24] In the fourth paragraph on page 370, the sixth paragraph should read: Therefore, the MS/MS study of several different classes of substances is necessary to furnish information about their fragmentation pathways. [24] The following reference should be added at the end of the list on page 378: 
